By: Elowen Gray
America’s healthcare reimbursement system was not designed to reward prevention. It was designed to reward volume: the number of procedures performed, the number of appointments billed, the number of interventions delivered. For decades that structure has shaped how care is organized, where investment flows, and which models of delivery get built and sustained at scale.
Tashiba Williams, NP-C, founder of ADA Family Health Clinic, has spent more than 25 years watching what that structure produces at the patient level. The answer, particularly for the millions of Americans managing chronic wounds, is a system that consistently pays more for worse outcomes than it would cost to deliver better ones.
That is not a philosophical critique. It is a financial reality, and the numbers behind it are significant enough to demand the attention of every stakeholder in the American healthcare economy.
The Cost Structure Nobody Wants to Talk About
Chronic wounds affect more than 6 million Americans annually and cost the healthcare system tens of billions of dollars each year. The majority of that cost is concentrated not at the beginning of the wound care timeline, where early intervention is relatively inexpensive, but at the end of it, where hospitalizations, surgical procedures, and amputations generate the kind of per-patient expenditures that strain hospital budgets, insurance reserves, and government healthcare programs simultaneously.
The average cost of treating a diabetic foot ulcer that progresses to amputation, including the surgical procedure, inpatient stay, rehabilitation, prosthetics, and long-term follow-up care, can exceed $500,000 over a patient’s lifetime. The cost of the consistent, specialized outpatient wound care that could have prevented that progression is a fraction of that figure, often manageable within standard outpatient reimbursement structures if the care is delivered early and consistently enough.
The system, in other words, is structured to spend dramatically more money on the outcome it is supposed to prevent than it would cost to prevent it. And the primary reason that spending pattern persists is not clinical. It is structural. The reimbursement model does not adequately incentivize the early, consistent, mobile intervention that produces better outcomes at lower cost.
“Chronic wounds represent a multibillion-dollar challenge for the healthcare system,” Williams said. “Mobile wound care is one of the most practical ways to address both sides of the equation: improving access for patients while helping healthcare organizations manage costs more effectively.”
Where Mobile Care Fits Into the Economics
The financial case for mobile wound care begins with a simple observation: the patients most likely to experience wound deterioration and its associated costs are also the patients for whom the conventional clinic-based model creates the most access friction.
Elderly patients, those managing diabetes and vascular disease, and individuals in underserved communities all face transportation barriers, referral delays, and follow-up inconsistencies that create gaps in treatment. Those gaps are where wounds worsen. Worsened wounds generate hospitalizations. Hospitalizations generate costs that dwarf the expense of the mobile visit that could have prevented them.
Williams built ADA Family Health Clinic around eliminating those gaps. By bringing specialized wound care directly to patients in their homes across Texas and Louisiana, her practice reduces the missed appointments and treatment interruptions that most reliably drive wound deterioration and downstream costs. Since launching, she has treated more than 343 patients, including multiple individuals who avoided amputations they had been told were likely outcomes.
Each avoided amputation represents not only a preserved limb but a avoided cost cascade. Surgical fees, inpatient days, rehabilitation programs, prosthetics, home care, and the ongoing management of post-amputation complications all disappear from the ledger when a wound heals instead of progressing. The return on investment for early mobile intervention, measured in avoided downstream expenditure alone, is substantial.
The Value-Based Care Opportunity
The broader healthcare industry has been slowly but meaningfully moving toward a value-based care reimbursement model, one that ties payment to patient outcomes rather than service volume. That shift represents the most significant structural opportunity for mobile wound care to scale from a model practiced by pioneering individual clinicians into a standard component of how chronic wound management is organized and funded at a system level.
Under value-based frameworks, the outcomes mobile care reliably produces, reduced hospitalization rates, lower complication frequencies, fewer amputations, align directly with the metrics that drive reimbursement. The financial friction that has historically made it difficult for independent mobile practices to sustain themselves under fee-for-service structures diminishes considerably when the system is designed to reward results rather than volume.
Williams sees that alignment as one of the clearest and most underutilized opportunities in modern healthcare finance.
“As the population ages and chronic conditions like diabetes become more prevalent, the demand for wound care will continue to rise,” Williams said. “Mobile care models allow clinicians to meet patients where they are, which not only improves continuity of care but also supports the future of value-based healthcare.”
The demographic projections reinforce the urgency. The American population is aging. Diabetes rates continue to climb. The number of patients who will require consistent, specialized wound care over the coming decade is not a speculative figure. It is a near certainty, and the existing infrastructure of clinics and hospitals is not positioned to absorb that demand without dramatically increasing the cost burden on every part of the system that pays for chronic disease management.
What Needs to Change
The reimbursement barriers that currently limit the scalability of mobile wound care are not insurmountable, but they require deliberate action from the stakeholders with the authority to address them.
Insurance and government reimbursement structures need to better reflect the cost savings generated by mobile and preventive care models. The current tendency to reimburse crisis intervention at a higher rate than consistent preventive monitoring creates a perverse incentive that pushes the system toward exactly the expensive outcomes it is trying to avoid.
Scope of practice regulations, which vary significantly by state and in some cases require physician oversight of nurse practitioner-led practices, add operational complexity and cost to mobile models that are already navigating the logistics of multi-state service delivery. Streamlining those regulations in line with states that have already granted full practice authority to nurse practitioners would reduce friction for practices like Williams’ without compromising patient safety or clinical standards.
Finally, the investment community and health system administrators need to treat mobile wound care not as an ancillary or experimental service but as a core component of cost-effective chronic disease management. The evidence for its clinical and economic effectiveness exists. What is currently lacking is the structural commitment to integrate it into how care is financed and delivered at scale.
Williams has already built the proof of concept. The question for the healthcare finance community is whether it is paying attention.
“Mobile wound care reflects a broader shift in healthcare toward decentralized, patient-centered treatment,” she said. “By delivering specialized wound care directly to patients’ homes or care facilities, providers can intervene earlier, improve healing outcomes, and reduce the costly complications that often result from delayed care.”
The reimbursement system is currently paying for the wrong thing. The model that pays for the right thing already exists. It just needs the financial infrastructure to match.
